Medicup logoMedicup
← Back to Blog & News

Industry News

The Next Big Thing in Medicine? 'Deprescribing' Just Got a $7M Boost

via MedCity News2 min read
Digital HealthTelehealthHealth TechVenture CapitalPatient SafetyMedication ManagementDeprescribing
The Next Big Thing in Medicine? 'Deprescribing' Just Got a $7M Boost

Getting a prescription is a familiar part of modern healthcare. But what about the process of safely stopping a medication? A startup named Outro is tackling this very challenge, and it just secured $7 million in funding to build out its platform for what's known as “safe deprescribing.”

The investment round saw participation from a range of venture firms, including Listen Ventures, Cake Ventures, and Jason Calicanis’s LAUNCH, signaling strong confidence in this emerging area of medicine.

Deprescribing is the planned, supervised process of stopping medications that may no longer be necessary, are causing side effects, or are no longer providing a benefit. As people age or manage multiple chronic conditions, they often accumulate a long list of prescriptions—a situation that can increase the risk of adverse drug interactions and reduce quality of life.

The Medicup Perspective: Why Deprescribing is a Digital Health Imperative

At Medicup, we see this as a critical evolution in patient-centered care, one that aligns perfectly with the strengths of digital health.

For patients, tools that support deprescribing offer a new level of empowerment. They provide the information and structure needed to have a confident conversation with a provider about medication goals. Telehealth platforms make it easier than ever to conduct the regular check-ins required for safely tapering off a drug, without the need for constant in-person visits.

For providers, managing complex medication regimens is a significant burden. Digital tools that streamline the deprescribing process can save time, reduce clinical risk, and help them deliver more personalized care. By integrating deprescribing protocols into a provider's workflow—much like the EMR and prescribing tools we build at Medicup—we can make it a standard, safe, and efficient part of practice.

Outro's funding is more than just a business headline; it’s a sign that the healthcare industry is recognizing the need to not only start medications, but to thoughtfully and safely stop them, too. It's a future where technology helps ensure every patient is on the right medication, at the right dose, for only as long as it's truly needed.

Source: MedCity News

Originally reported by MedCity News. This summary and Medicup's perspective are written independently.